BioSpace News Archive

FDA

Nonprofit Wins FDA Approval for Tuberculosis Drug

TB Alliance became the first nonprofit organization to win regulatory approval from the U.S. Food and Drug Administration for a new drug aimed at treating some of the most drug-resistant forms of tuberculosis.

August 15, 2019

·

2 min read

·

Alex Keown

Business

BioSpace Movers & Shakers, Aug. 16

Biopharma companies strengthen their executive ranks and boards with new additions.

August 15, 2019

·

6 min read

·

Alex Keown

Genetown

IDTechEx Forecasts Advanced Wound Care Market to Exceed $22 Billion by 2030

IDTechEx, a market intelligence company focusing on emerging technologies, has released a new report titled “Advanced Wound Care Technologies 2020–2030”.

August 15, 2019

·

2 min read

Business

Cal State LA honors renowned microbiologist, emerging bioscience entrepreneurs

Jill Adler-Moore, a renowned microbiologist and professor emerita at Cal Poly Pomona, was honored for her research, leadership and years of mentorship during a Cal State LA BioSpace event celebrating emerging entrepreneurs.

August 15, 2019

·

4 min read

Arizona State University Researchers Try Novel Approach to Alzheimer’s Prevention

Researchers at Arizona State University are experimenting with a compound that might prevent Alzheimer’s and other neurodegenerative diseases, such as Parkinson’s disease, and potentially Down syndrome.

August 15, 2019

·

2 min read

·

Mark Terry

FDA

FDA Approves First Non-Controlled Substance Treatment for Narcolepsy

The FDA approved Wakix for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

August 15, 2019

·

2 min read

·

Alex Keown

BioMidwest

Merix Pharmaceutical Corp. Announces RELEEV® 1 Day Cold Sore Treatment Now Available in Airports, Providing On-the-Go Relief

Botanical-derived formula highly active against HSV-1 and HSV-2 flares that occur during travel

August 15, 2019

·

2 min read

Business

Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome

Under the terms of the deal, Utragenyx will pay GeneTx $20 million for an exclusive option to acquire GeneTx.

August 15, 2019

·

3 min read

·

Mark Terry

Business

A Family Affair: Kaspar Brothers Replaced at AveXis Amid Data Manipulation Scandal

In a brief announcement, AveXis said the Kaspar brothers have not been involved in any operations at AveXis since early May, seemingly ahead of the U.S. Food and Drug Administration’s approval of Zolgensma.

August 15, 2019

·

2 min read

·

Alex Keown

Career Advice

How to Negotiate Work-Life Balance into a Job Offer

When you’re evaluating a job offer it can be hard to look past the salary. But if a company can’t budge on their budget, it’s time to think about other things they may be able to offer you.

August 15, 2019

·

3 min read

·

Laura Brothers